IFNG and non-small cell lung carcinoma: In the current study, we analyzed metagenomic differences between two subgroups of NSCLC patients split according to the median value of hTERT-specific IFNγ secreting T lymphocytes (110 spots per 3×105 PBMC detectable by mean of an enzyme-linked immunosorbent spot (by ex vivo ELISPOT assay) (Table S5c, Table S7,Fig. 4B).